ClinicalTrials.govpublic full text
Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients
schizophrenia; psychosis, metabolic syndrome, flupentixol, antipsychotic agents, central nervous system diseases, clinical therapy, olanzapine, quetiapine, schizophrenia, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 850760
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.